Submitted:
19 July 2026
Posted:
21 July 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Mode of Action of Oxygen Enriched Oils (OELs) in Wound Healing
2.1. The Composition of OELs
2.2. Interaction of OEL with the Wound Bed
2.3. Role of H2O2 Generation from OEL Within the Wound Bed

2.4. Role of fatty Acid Generation from OEL Within the Wound Bed
2.5. Summary
3. Clinical Application
3.1. Burns and Acute Wounds
3.1.1. Burns
3.1.2. Acute Wounds (Non-Surgical)
3.2. Post-Surgical Wounds
3.2.1. Hidradenitis Suppurativa
3.2.2. Pilonidal Sinus Disease and Pediatric Surgical Wounds
3.2.3. Oncologic and Reconstructive Surgery
3.3. Chronic Leg Ulcers
4. Discussion
- Burns: superior to silver-based agents, with faster healing and lower pain.
- Pilonidal sinus disease: robust evidence in both adults and children, especially within minimally invasive PEPSIT protocols.
- HS and Fournier gangrene: effective in contaminated and chronic wound environments.
- Oncologic/reconstructive surgery: improved healing and fewer complications in patients at high risk of impaired wound repair.
- Pediatrics: safe, well-tolerated, and associated with improved recovery experiences.
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| BWAT | Bates Wound Assessment Tools |
| EPSIT | Endoscopic Pilonidal Sinus Treatment |
| HS | Hidradenitis Suppurativa |
| NPWT | Negative Pressure Wound Therapy |
| OEL | Oxygen Enriched Oils |
| OEOM | Oxygen-Enriched Oleic Matrix / Matrices |
| PEPSiT | Patient and Observer Scar Assessment Scale |
| POSAS | Pediatric endoscopic pilonidal sinus treatment |
| QoL | Quality of Life |
| RCT | Randozimed Control Trial |
| ROS | Reactive Oxygen Species |
| TAG | Tryacylglycerol |
| TBSA | Total Body Surface Area |
| VAS | Visual Analogue Scale |
| VLU | Venous Leg Ulcer |
| WBS | Wound Bed Score |
References
- Sen, C.K. Wound healing essentials: let there be oxygen. Wound Repair Regen. 2009, 17(1), 1–18. [Google Scholar] [CrossRef] [PubMed]
- van der Vliet, A.; Janssen-Heininger, Y.M. Hydrogen peroxide as a damage signal in tissue injury and inflammation: murderer, mediator, or messenger? J. Cell Biochem. 2014, 115(3), 427–35. [Google Scholar] [CrossRef] [PubMed]
- Loo, A.E.; Wong, Y.T.; Ho, R.; Wasser, M.; Du, T.; Ng, W.T.; Halliwell, B. Effects of hydrogen peroxide on wound healing in mice in relation to oxidative damage. PLoS ONE 2012, 7(11), e49215. [Google Scholar] [CrossRef] [PubMed]
- Ugazio, E.; Tullio, V.; Binello, A.; Tagliapietra, S.; Dosio, F. Ozonated Oils as Antimicrobial Systems in Topical Applications. Their Characterization, Current Applications, and Advances in Improved Delivery Techniques. Molecules 2020, 25(2), 334. [Google Scholar] [CrossRef] [PubMed]
- Radzimierska-Kazmierczak, M.; et al. Olive Oil with Ozone-Modified Properties and Its Application. Molecules 2021, 26(11). [Google Scholar] [CrossRef] [PubMed]
- Criegee, R. Mechanism of Ozonolysis. Angew. Chem. Int. Ed. Engl. 1975, 14, 745–752. [Google Scholar] [CrossRef]
- Falanga, V.; et al. Chronic wounds. Nat. Rev. Dis. Prim. 2022, 8(1), 50. [Google Scholar] [CrossRef] [PubMed]
- Niethammer, P.; et al. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 2009, 459(7249), 996–9. [Google Scholar] [CrossRef] [PubMed]
- Cipriani, F.; Lucattelli, E.; De Rosa, M.; Di Lonardo, A. Effectiveness of reactive oxygen species in an oil-based medication for healing burn wounds: a case series. Ann. Burn. Fire Disasters 2021, 34, 170–174. [Google Scholar]
- Detmar, M.; Brown, L.F.; Berse, B.; Jackman, R.W.; Elicker, B.M.; Dvorak, H.F.; Claffey, K.P. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J. Invest. Dermatol. 1997, 108, 263–268. [Google Scholar] [CrossRef] [PubMed]
- Grolman, R.E.; Wilkerson, D.K.; Taylor, J.; Allinson, P.; Zatina, M.A. Transcutaneous oxygen measurements predict a beneficial response to hyperbaric oxygen therapy in patients with nonhealing wounds and critical limb ischemia. Am. Surg. 2001, 67, 1072–1079. [Google Scholar] [CrossRef] [PubMed]
- Sen, C.K.; Khanna, S.; Gordillo, G.; Bagchi, D.; Bagchi, M.; Roy, S. Oxygen, oxidants, and antioxidants in wound healing: an emerging paradigm. Ann. N. Y. Acad. Sci. 2002, 957, 239–249. [Google Scholar] [CrossRef] [PubMed]
- Schreml, S.; Szeimies, R.M.; Prantl, L.; Karrer, S.; Landthaler, M.; Babilas, P. Oxygen in acute and chronic wound healing. Br. J. Dermatol. 2010, 163, 257–268. [Google Scholar] [CrossRef] [PubMed]
- Arduino, P.G.; Cabras, M.; Macciotta, A.; Longhi, F.; Gambino, A.; Broccoletti, R. A single-center prospective pilot open-label study to assess the efficacy of topical application of an oxygen-enriched oil for the treatment of angular cheilitis. J. Oral Sci. 2022, 64, 105–108. [Google Scholar] [CrossRef] [PubMed]
- Montevecchi, M.; Dorigo, A.; Cricca, M.; Checchi, L. Comparison of the antibacterial activity of an ozonated oil with chlorhexidine digluconate and povidone-iodine: a disk diffusion test. New Microbiol. 2013, 36, 289–302. [Google Scholar] [PubMed]
- Nicolosi, B.; García-Molina, P.; Veggi, S.; Pinzauti, E.; Pancani, S. Oxygen-enriched oleic matrix medical dressings for the treatment of extensive burns and related acute and post-burn complications in children: a case series. Wounds UK 2024, 20, 46–51. [Google Scholar] [CrossRef]
- Marinelli, E.; Sandroni, S.; Salutini, E. Utilizzo di medicazione a rilascio di ROS nella gestione di lesione post esposizione a raggi solari riflessi su specchio post estricazione complessa. Ital. J. Wound Care 2024, 8(2). [Google Scholar] [CrossRef]
- Arduino, P.G.; Cabras, M.; Broccoletti, R. Hyper-oxidized oil in the management of oral mucosal diseases: a case series. Dent. Cadmos 2016, 84, 262–266. [Google Scholar]
- Zanetti, C. Wound care in a child suffering from Stevens-Johnson syndrome in PICU: case report. Inferm. J. 2024, 3, 9–13. [Google Scholar] [CrossRef]
- Mitro, V.; Giovacchini, F.; Gill, i M.; Monarchi, G.; Caso, A.R.; Bimonte, A.; Lombardo, G.; Tullio, A. Effects of the Application of an Oxygen-Enriched Oil-Based Dressing (NovoX®-Drop) After Extraction of Impacted Lower Third Molars: A Randomized Controlled Study. J. Clin. Med. 2025, 14(14), 4986. [Google Scholar] [CrossRef] [PubMed]
- Parente, G.; Ruspi, F.; Thomas, E.; Di Mitri, M.; Cravano, S.M.; D’Antonio, S.; Gargano, T.; Lima, M. Endoscopic Pilonidal Sinus Treatment: Preliminary Results, Learning Curve and Comparison with Standard Open Approach. Children . 2023, 10(6), 1063. [Google Scholar] [CrossRef] [PubMed]
- Esposito, C.; Mendoza-Sagaon, M.; Del Conte, F.; Cerulo, M.; Coppola, V.; Esposito, G.; Cortese, G.; Crocetto, F.; Montaruli, E.; Escolino, M. Pediatric Endoscopic Pilonidal Sinus Treatment (PEPSIT) in Children With Pilonidal Sinus Disease: Tips and Tricks and New Structurated Protocol. Front. Pediatr. 2020, 8, 345. [Google Scholar] [CrossRef] [PubMed]
- Bisol, M.; Tykhomyrova, S.; Pagliara, C.; Scarpa, M.G.; Guida, E.; Olenik, D.; Codrich, D.; Schleef, J.; Boscarelli, A. Oxygen-enriched oleic matrix (NovoX) for wound healing in pediatric patients undergoing open surgical treatment for pilonidal disease: Preliminary experience. Front Pediatr. 2022, 10, 1068280. [Google Scholar] [CrossRef] [PubMed]
- Guarro, G.; Carella, S.; Cordellini, M. Use of hyperoxidized oils-based medical devices for the wound healing in post-surgical patients. Acta BioMed 2023, 94 Supplement 1, e2023151. [Google Scholar] [PubMed]
- Zouboulis, C.C.; Desai, N.; Emtestam, L.; Hunger, R.E.; Ioannides, D.; Juhász, I.; Lapins, J.; Matusiak, L.; Prens, E.P.; Revuz, J.; Schneider-Burrus, S.; Szepietowski, J.C.; van der Zee, H.H.; Jemec, G.B. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J. Eur. Acad. Dermatol. Venereol. 2015, 29, 619–644. [Google Scholar] [CrossRef] [PubMed]
- Dini, V.; Oranges, T.; Rotella, L.; Romanelli, M. Hidradenitis suppurativa and wound management. Int. J. Low. Extrem Wounds. 2015, 14(3), 236–244. [Google Scholar] [CrossRef] [PubMed]
- Moloney, S. The challenges of wound management for hidradenitis suppurativa. Br. J. Nurs. 2022, 31(4), S34–S41. [Google Scholar] [CrossRef] [PubMed]
- Kazemi, A.; Carnaggio, K.; Clark, M.; Shephard, C.; Okoye, G.A. Optimal wound care management in hidradenitis suppurativa. J. Dermatol. Treat. 2018, 29(2), 165–167. [Google Scholar]
- Michelucci, A.; Janowska, A.; Granieri, G.; Margiotta, F.M.; Morganti, R.; Romanelli, M.; Dini, V. Advanced wound management approaches in Hidradenitis Suppurativa postsurgical lesions. Health Sci. Rep. 2023, 6(10), e1582. [Google Scholar] [CrossRef] [PubMed]
- Esposito, C.; Del Conte, F.; Cerulo, M.; Coppola, V.; Esposito, G.; Ricciardi, E.; Castagnetti, M.; Fabbrocini, G.; Escolino, M. Pediatric Endoscopic Hidradenitis Treatment: A New Minimally Invasive Treatment for Pediatric Patients with Hidradenitis Suppurativa. J. Laparoendosc. Adv. Surg. Tech A 2020, 4, 464–470. [Google Scholar] [CrossRef]
- Cioppa, T.; Dreoni, P.; Giani, J.; Linari, C.; Caminati, F.; Calistri, M. Treatment of Perianal Fournier’s Gangrene with an Oxygen-Enriched Oil Based Medical Device NOVOX (®) Roll: Case Report. World J. Surg. Surg. Res. 2022, 1371, 5. [Google Scholar]
- Santorelli, A.; Bernini, M.; Orzalesi, L.; Avvedimento, S.; Palumbo, P.; Kothari, A.; Fausto, A.; Magalotti, C.; Buzzi, G.; Sandroni, S.; Calabrese, C. Treatment With Oxygen-Enriched Olive Oil Improves Healing Parameters Following Augmentation-Mastopexy. Aesthet. Surg. J. Open Forum 2021, 3(3), ojab016. [Google Scholar] [CrossRef] [PubMed]
- Magalotti, C.; Nisi, M.; Pastor Ruiz, E.; Romiti, C.; Tinti, A.; Barillaro, I.; Muccitelli, A.; Franchini, L.; Brera, D.; Guarro, G. Enhanced Postoperative Evaluation in Oncoplastic Breast Surgery With Interactive Versus Traditional Dressings: A Comparative Study. Plast. Reconstr. Surg. Glob. Open 2025, 13(4), e6724. [Google Scholar] [CrossRef] [PubMed]
- Casella, D.; Palumbo, P.; Sandroni, S.; Caponi, C.; Littori, F.; Capuano, F.; Grimaldi, L.; Marcasciano, M.; Cuomo, R.; et al. Positive ROS (Reactive Oxygen Species) Modulator Engineered Device Support Skin Treatment in Locally Advanced Breast Cancer (LABC) Enhancing Patient Quality of Life. J. Clin. Med. 2021, 11(1), 126. [Google Scholar] [CrossRef] [PubMed]
- Colella, R.; Rossi, M. Biotechnological innovations: role of a reactive oxygen species release device in the management of pilonidal cysts. Wounds Int. 2021, 12, 45–48. [Google Scholar] [CrossRef]
- Laureti, S.; Aborajooh, E.; Mattioli, B.; Poggioli, G. Treatment of minor dehiscence after endorectal advancement flap in perianal Crohn’s fistulas with ozonized oil NOVOX®. Tech Coloproctol. 2015, 19, 755–757. [Google Scholar]
- Sordi, S.; Kaciulyte, J.; Araby, M.M.E.; Luridiana, G.; Marchesi, A.; Gatto, A.; Seth, I.; Rozen, W. M.; Casella, D.; Cuomo, R. Streamlining outpatient prepectoral breast reconstruction: The role of polyurethane oxygen-enriched bra cups from pandemic innovation to standardized cost analysis. Il G. Di Chir. – J. Ital. Surg. Assoc. 2024, 44(6), e59. [Google Scholar] [CrossRef]
- Esposito, C.; Coppola, V.; Del Conte, F.; Cerulo, M.; Esposito, G.; Crocetto, F.; Castagnetti, M.; Calignano, A.; Escolino, M. Evaluation of a New Tubular Finger Oxygen-Enriched Oil Inside-Coated Dressing Device in Pediatric Patients Undergoing Distal Hypospadias Repair: A Prospective Randomized Clinical Trial Part II. Front. Pediatr. 2021, 9, 638406. [Google Scholar] [CrossRef] [PubMed]
- Materni, A.; Pasquale, C.; Longo, E.; Frosecchi, M.; Benedicenti, S.; Bozzo, M.; Amaroli, A. Prevention of Dry Socket with Ozone Oil-Based Gel after Inferior Third Molar Extraction: A Double-Blind Split-Mouth Randomized Placebo-Controlled Clinical Trial. Gels 2023, 9(4), 289. [Google Scholar] [CrossRef] [PubMed]
- Cassino, R.; Ippolito, A.M.; Cuffaro, P.; Corsi, A.; Forma, O. Evaluation of the effectiveness of a hyperoxidized oil-based medication in the treatment of skin lesions: observational study. Minerva Chir. 2015, 70, 23–31. [Google Scholar] [PubMed]
- Power, G.; Moore, Z.; O’Connor, T. Measurement of pH, exudate composition and temperature in wound healing: a systematic review. J. Wound Care 2017, 26, 381–397. [Google Scholar] [CrossRef] [PubMed]





| Product type | Composition/formulation | Key mechanism | Typical clinical applications | Regulatory status |
| Oxygen-enriched oil-based matrix gel-like dressings | Oxygen-enriched oil (Oils enriched with oxygen through chemical interaction with O2/O3 oxygenating gas) + parfuming / flavoring excipients | Controlled release of carboxylic acids and ROS microquantities with balanced kinetics | Hard-to-heal chronic and cavitary wounds (skin and oral applications) Superficial, mid-deep and deep burns |
Medical Devices according to EU MDR Regulation (including adult and pediatric patient populations) |
| Oxygen-enriched oil-based matrix impregnated bandages / gauzes | Impregnated bandage/gauze: Bandage rolls or gauze pads impregnated with Oxygen-enriched oil gel-like ointments (as above) |
Controlled release of carboxylic acids and ROS microquantities (as above) + mechanical protection | Hard-to-heal chronic and cavitary wounds (skin and ENT applications) Superficial, mid-deep and deep burns |
Medical Devices according to EU MDR Regulation (including adult and pediatric patient populations) |
| Oxygen-enriched oil-based matrix on shaped supports. | Oxygen-enriched oil gel-like ointments (as above) embedded in polyurethane supports (cups, pads, tubular dressings) | Combined mechanical protection + ROS and carboxylic acids microquantities controlled release | Surgical wounds (Oncoplastic breast surgery, pediatric hypospadias repair, PSD) Superficial and mid-deep burns |
Medical Devices according to EU MDR Regulation (including adult and pediatric patient populations) |
| Ozonized oleic matrices (O₃-oils) | Vegetable oils (olive, sunflower, flaxseed) reacted with ozone, forming ozonides and peroxides | ROS release, antimicrobial + pro-regenerative | Burns, acute wounds, pilonidal sinus disease | Some products approved as Medical Devices, others nor approved |
| Hyperoxidized oil-based gels | High peroxidized lipid content in hydrogel carrier | ROS delivery + hydration | Chronic ulcers, recalcitrant wounds | Some products approved as Medical Devices, others nor approved |
| Hydrogel/emulsion-based matrices | Oil-in-water gels, emulsions, sprays with oxidized oils | Hydration + ROS release | Oral ulcers, Stevens–Johnson syndrome, pediatrics | Some products approved as Medical Devices, others nor approved |
| Experimental nanocarriers | Liposomes, nanostructured lipid carriers (NLCs) with ozonized oils | Enhanced penetration, stability, targeted ROS release | Preclinical research, potential dermatology use | Not approved as medical devices. Experimental and R&D uses only |
| Clinical setting | Formulation | Protocol | Population treated | Main results | Healing/outcome time | Reference |
|---|---|---|---|---|---|---|
| Mid–deep and deep burns (TBSA ~23%) | Gel-like dressing Impregnated pad/gauze |
Every 48 hours | 20 patients | Faster reduction of pain, exudate, and bacterial load | Negative cultures in 4 days (vs 8 days control) | Cipriani 2021 |
| Pediatric burns II–III degree (>15% TBSA) | Gel-like dressing Impregnated pad/ bandage (depending on the site) |
Every 3 days | 3 patients | Infection control, reduced itching, better scarring, improved healing process | Healing in 21.7 days (mean value) | Nicolosi 2024 |
| 3rd degree thigh burn | Impregnated gauze pad. | Daily | 1 patient | Pain reduction (VAS 10→0), Bates Wound Assessment Tools (BWAT) reduction (51 → 14), high satisfaction |
Complete healing in 45 days | Marinelli 2024 |
| Traumatic oral ulcers | Gel-like dressing | 3×/day for 1 week | 21 patients | Significant reduction in pain and lesion size | Healing within 7 days | Arduino 2016 |
| Stevens-Johnson syndrome, pediatric | Gel-like dressing | Daily mucosal dressing; other lesions treated every 48h | 1 patient | Progressive mucosal and cutaneous healing, pain control, preserved function and minor residual damage | Lesion improvement from day 7; trunk/limbs healed by ~28d; full recovery with minor residuals | Zanetti 2024 |
| HS, post wide local excision | Gel-like dressing | Twice a week | 25 patients | Wound area ↓, WBS improved, pain ↓ | 4 weeks, ~81% area reduction | Michelucci 2023 |
| Pediatric HS (endoscopic treatment) | Gel-like dressing | 2 times/ day for at least 4 weeks | 11 patients | Painless recovery, 0% recurrency and mean VAS 0.7 during the first 24 hours; | Average healing time: 32.5 days (range 30–45) | Esposito 2020 |
| Pediatric pilonidal sinus, post-surgery | Gel-like dressing Impregnated bandage (in 1 case) |
Once weekly | 3 patients | Good cosmetic outcome, slightly faster healing, safe | Average healing time: ~5 weeks | Bisol 2022 |
| Pediatric pilonidal disease (PEPSiT) | Gel-like dressing | Twice daily for 2-3 weeks | 72 patients | Faster healing, fewer recurrences (2.1% vs 15%), lower infection rate | Median healing 21 days vs 28.1 days (sulfadiazine) | Esposito 2020 |
| Pilonidal disease (EPSiT/open) | Gel-like dressing | ≈ every 3–4 days | 11 patients (total of 39 EPSiT patients) | Fewer dressings, lower recurrence | Healing in 38.3 ± 23.5 days (overall EPsiT) | Parente 2023 |
| Pediatric distal hypospadias repair | Tubular shaped support with embedded oxygen-enriched oil | Applied intraoperatively and left in place postoperatively—precise schedule for changes not specified | RCT, 64 patients | Faster healing, fewer complications, easier handling | Healing in 14.2 days | Esposito 2021 |
| Recurrent pilonidal cyst (7 prior surgeries) | Gel-like dressing | Daily from Day1 to Day 15, then every 48/72 hours | 1 patient | Healing achieved, pain ↓, QoL ↑ | Healing completed after 8 weeks | Colella 2021 |
| Advanced breast cancer skin ulcers | Gel-like dressing + Cup shaped support with embedded oxygen-enriched oil OR Gel-like dressing + Cup shaped support with embedded oxygen-enriched oil + impregnated gauze (largest lesions) |
Daily changes for 30 days | 20 patients | ↓ ulceration, exudate, odor; safe in neoplastic tissue | Progressive improvement in 30 days | Casella 2021 |
| Oncoplastic breast surgery | Cup shaped support with embedded oxygen-enriched oil | Immediate application postsurgery and regular replacements up to 6 weeks postoperatively | 376 patients | Better healing, less pain, higher satisfaction | 87.3% of wounds treated with the interactive dressing achieved full re-epithelialization in 4 weeks | Magalotti 2025 |
| Post-reconstructive lower limb wound | Impregnated gauze pad | Every 48 hours initially, then every 72 hours and during the final month of treatment, once weekly | 1 patient | Progressive wound reduction, home use feasible | Gradual healing in 103 days | Guarro 2023 |
| Prepectoral mastectomy reconstruction | Cup shaped support with embedded oxygen-enriched oil | 8 changes in 30 days | 125 patients | Fewer clinic visits (10→3), cost savings, ↑ autonomy | Healing within 1 month in almost all patients | Sordi 2024 |
| Augmentation–mastopexy | Cup shaped support with embedded oxygen-enriched oil | Continuous maintenance for 2 weeks postoperatively | 120 patients | Less pain early post-op, better long-term scar | Pain assessed at days 2, 3, 10; scars assessed at 6 & 12 months — significantly lower pain and better POSAS scores in treatment arm | Santorelli 2021 |
| Impacted third molar extraction | Gel-like dressing | 3 times daily after oral hygiene for seven consecutive days | RCT, 35 patients | Less pain, fewer Non-Steroidal Anti-Inflammatory Drugs, improved trismus control | Improvement in 7 days (observation time) | Mitro 2025 |
| Third molar extraction | Gel-like dressing | Once daily during the first 3 postoperative days; 14 days follow-up | RCT on 200 patients (total 400 extraction sites) | Lower dry socket incidence | Complete epithelialization within early post-op days | Materni 2023 |
| Fournier’s gangrene, post-debridement | Impregnated bandage | 3 dressings/week for the first 15 days and 2 dressings in the following two weeks |
1 patient | Complete closure, less exudate, more granulation | Complete healing (time not detailed) |
Cioppa 2022 |
| Chronic leg ulcers (arterial, venous, mixed, inflammatory, traumatic) | Gel-like dressing | Every 48h (daily if high exudate), 4 weeks | 50 patients | >50% area reduction, WBS improved, pain ↓, ↓ analgesics, no infections | Complete healing in 6% within 4 weeks; improvement in all | Cassino 2015 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).